CClinicalTrials.gg
RecruitingNCT06683170Updated Jun 22, 2026

Validity and Feasibility of the Pregnancy Monitoring Belt - a Clinical Pilot Study

An observational study in Validation, sponsored by Anna Axelin. Recruiting at 1 site in Finland. Open to female participants. Per ClinicalTrials.gov, last updated 2026-06-22.

Sponsored by Anna Axelin · Observational

From the registry’s dates

  • Started Jun 2026; still recruiting 4 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
35
Sex
Female
01

Study summary

The aims of this clinical pilot study are to:

  1. to validate the following parameters: mother heart rate, mother ECG, fetal heart rate, contractions, mother oxygen saturation, mother breathing rate, mother blood pressure
  2. to evaluate the feasibility on detecting fetal movements
  3. to explore how pregnant women and health care professionals perceive the acceptability and usability of the pregnancy monitoring system
  4. to explore the possibility to support prenatal attachment between parent and fetus with remote pregnancy monitoring

The participating pregnant women will wear the pregnancy monitoring belt for 2 hours during of which, the data will be collected with pregnancy monitoring belt and patient monitor (reference device). The data from the pregnancy monitoring belt will be compared with the patient monitor data referred as golden standard. The acceptability and usability will be assessed by pregnant women and healthcare professionals by fulfilling a questionnaire and participating in interviews. The data collection will be conducted in hospital environment.

02

Conditions studied

  • Validation
03

In context

Lead sponsor

Anna Axelin is the lead sponsor of 3 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Pregnant women will be recruited from different units participating in pregnancy care: maternity clinics, pregnancy outpatient clinic and pregnancy follow-up ward. The monitoring during the data collection will not affect the normal pregnancy monitoring practices. The recruitment will be conducted via social media.

The healthcare professionals will be recruited also from different units in the area of Wellbeing services county of Southwest Finland: pregnancy follow-up ward, labour ward, maternity outpatient clinic and maternity clinics. The recruitment will be conducted via work email.

Eligibility criteria

Inclusion criteria for pregnant women:

  • duration pf pregnancy at least 29+0 weeks
  • single pregnancy
  • age at least 18 years
  • ability to participate in Finnish No exclusion criteria

Inclusion criteria for healthcare professionals:

  • being a healthcare professional working with pregnant women
  • being able to participate in Finnish No exclusion criteria
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
35 participants (estimated)
Patient registry
No

Groups and cohorts

  • Pregnant women

    Pregnant women wearing the pregnancy monitoring belt for two hours. In addition, the hospital patient monitor will be used to measure mother ECG, heart rate, breathing rate, oxygen saturation, blood pressure, contractions and fetal heart rate and movements.

  • Healthcare professionals

    Healthcare professionals participating in the pregnancy care.

06

What researchers measure

Primary outcomes

  1. fetal heart rate

    Fetal heart rate will be measured with the sensorized pregnancy monitoring belt and to evaluate the accuracy of the measurements, the fetal heart rate measurements will be compared with the hospital patient monitor (golden standard).

    Time frame: Two hour data collection

07

Study locations

1 of 1 sites recruiting
  • Turku University Hospital
    Turku, Finland
    • Anna Axelin, Professor · Contact · anmaax@utu.fi · +358405029905
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06683170
Lead sponsor
Anna Axelin
Responsible party
Anna Axelin (Professor, University of Turku) — Sponsor-investigator
First posted
Nov 12, 2024
Start date
Jun 5, 2026
Primary completion
Sep 2026 (estimated)
Completion
Sep 2026 (estimated)
Last update
Jun 22, 2026

Study contacts

Susanna Likitalo
Contact
smliki@utu.fi
+358405652818
Anni Pakarinen
Contact
ankorh@utu.fi
+358504409740

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion